Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Model: ASHS provides Gamma Knife stereotactic radiosurgery services to medical centers through its 81% interest in GK Financing, LLC (GKF). The remaining 19% is owned by Elekta AG. Revenue is derived 100% from Gamma Knife operations via fee-per-use and revenue-sharing contracts. The company operates 17 units in the U.S. and has 3 additional sites under development.
Key Financial Metrics (Year Ended Dec 31, 2003)
| Metric | 2003 | 2002 | Change |
|---|---|---|---|
| Medical Services Revenue | $16,178,000 | $13,366,000 | +21.0% |
| Net Income | $1,382,000 | $1,102,000 | +25.4% |
| Net Income Per Share (Basic) | $0.36 | $0.30 | +20.0% |
| Operating Cash Flow | $8,140,000 | $5,177,000 | +57.2% |
| Total Assets | $46,304,000 | $44,830,000 | +3.3% |
| Total Debt (Long-term + Current) | $26,917,000 | $27,496,000 | -2.1% |
| Cash & Cash Equivalents | $10,312,000 | $9,924,000 | +3.9% |
| Working Capital | $5,268,000 | $7,175,000 | -26.6% |
Margins: Operating margin was approximately 18.4% ($2,976k / $16,178k). Net profit margin was approximately 8.5%.
Material Changes vs. Prior Period
- Revenue Growth: Driven by the addition of three new Gamma Knife units in 2003, full-year inclusion of two units started in 2002, and a 5% volume increase at existing sites. Total procedures increased to 2,116 (up 24.8% from 2002).
- Costs of Operations: Increased 37.1% to $7.4 million, primarily due to higher depreciation from new units, expiration of warranties on older units, and increased marketing/insurance costs. This raised the cost of operations as a percentage of revenue from 40.4% to 45.7%.
- Interest Expense: Increased slightly by 4.5% to $2.547 million due to financing for new units, partially offset by lower rates on mature debt.
- Dividends: The company paid $0.20 per share in dividends in 2003, up from $0.12 in 2002.
Outlook, Risks, and Contingencies
- Lender Bankruptcy: The company's primary lender, DVI Financial Services Inc., filed for Chapter 11 bankruptcy in August 2003. ASHS continues to make payments on outstanding notes but is seeking alternative financing for future projects. Management believes this will not have a material adverse effect.
- Reimbursement Risk: Revenue is sensitive to Medicare and third-party payer reimbursement rates. A shift to outpatient billing under the Ambulatory Product Classifications (APC) system reduced revenue at one site by an estimated $100,000 to $150,000 in 2003.
- Capital Intensity: The business requires significant capital investment (approx. $2.6 million per unit). The company has committed to purchasing future units totaling $9.543 million.
- Competition: Faces competition from conventional neurosurgery, modified linear accelerators, and direct sales by the manufacturer (Elekta).
- Future Projects: Three sites are under development, with one projected to be operational by mid-2004.
Investor Verification Checklist
- Financing Status: Verify the status of the DVI Financial Services bankruptcy proceedings and the company's ability to secure new debt for the $9.5 million in committed equipment purchases.
- Reimbursement Trends: Monitor Medicare APC rate changes and their impact on the four revenue-sharing contracts, which are directly exposed to payer rate reductions.
- Unit Utilization: Confirm the volume growth at the three new 2003 sites and the three sites under development to ensure they meet projected revenue targets.
- Customer Concentration: While no single customer exceeded 10% of revenue in 2003, verify the stability of the top customers (Yale and UAMS were >10% in 2002) given the shift in contract mix.
- Dividend Sustainability: Assess whether the increased dividend payout ($0.20/share) is sustainable given the capital requirements for new unit acquisitions and debt service.